id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0257-0001,FDA,FDA-2007-D-0257,See Document ID FDA-2007-D-0257-0003,Notice,,2007-12-28T00:00:00Z,2007,12,,,2008-05-21T20:22:03Z,,0,1,090000648042b1c1
FDA-2007-N-0313-0001,FDA,FDA-2007-N-0313,Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Product's Marketed Life Cycle; Public Workshop; Request for Comments,Notice,NM-Notice of Meeting,2007-12-26T05:00:00Z,2007,12,2007-12-21T05:00:00Z,2008-03-01T04:59:59Z,2008-08-15T01:38:12Z,,0,0,090000648042b70a
FDA-2007-N-0441-0001,FDA,FDA-2007-N-0441,"Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions; Correction",Notice,Correction,2007-12-26T05:00:00Z,2007,12,,,2025-08-19T20:11:21Z,E7-24914,0,0,090000648042dda7
FDA-2007-C-0044-0001,FDA,FDA-2007-C-0044,"DSM Nutritional Products, Inc.; Filing of Color Additive Petition; Correction",Notice,NCR-Notice of Correction,2007-12-26T05:00:00Z,2007,12,2007-12-21T05:00:00Z,,2026-01-08T20:18:17Z,,0,0,0900006480429648
FDA-2007-N-0152-0001,FDA,FDA-2007-N-0152,"Health Claims and Qualified Health Claims; Dietary Lipids and Cancer, Soy Protein and Coronary Heart Disease, Antioxidant Vitamins and Certain Cancers, and Selenium and Certain Cancers; Reevaluation; Opportunity for Public Comment",Notice,N-Notice,2007-12-21T05:00:00Z,2007,12,2007-12-21T05:00:00Z,2008-02-20T04:59:59Z,2008-07-08T18:53:47Z,,0,0,090000648042a409
FDA-2007-M-0452-0001,FDA,FDA-2007-M-0452,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-09T22:48:41Z,E7-24620,0,0,090000648042dec7
FDA-2007-M-0273-0001,FDA,FDA-2007-M-0273,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-09T21:15:57Z,E7-24620,0,0,090000648042b3c6
FDA-2007-M-0453-0001,FDA,FDA-2007-M-0453,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-10T00:23:52Z,E7-24620,0,0,090000648042ded7
FDA-2007-M-0325-0001,FDA,FDA-2007-M-0325,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-10T04:01:42Z,E7-24620,0,0,090000648042b804
FDA-2007-N-0382-0001,FDA,FDA-2007-N-0382,"Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting",Notice,Meeting,2007-12-19T05:00:00Z,2007,12,,,2025-08-19T15:55:54Z,E7-24629,0,0,090000648042d70f
FDA-2007-M-0397-0001,FDA,FDA-2007-M-0397,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-12T23:22:10Z,E7-24620,0,0,090000648042d84e
FDA-2007-M-0224-0001,FDA,FDA-2007-M-0224,FDA,Notice,NAL-Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2008-04-04T00:35:16Z,,0,0,090000648042ae2e
FDA-2007-M-0223-0001,FDA,FDA-2007-M-0223,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-09T23:33:10Z,E7-24620,0,0,090000648042ae1d
FDA-2007-M-0093-0001,FDA,FDA-2007-M-0093,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2007-12-19T05:00:00Z,2007,12,2007-12-19T05:00:00Z,,2026-01-13T00:37:18Z,E7-24620,0,0,0900006480429d20
FDA-2007-D-0306-0002,FDA,FDA-2007-D-0306,International Conference on Harmonisation; Draft Guidance on Q4B,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-02-16T04:59:59Z,2009-01-12T16:01:41Z,,0,0,090000648042b66c
FDA-2007-D-0200-0002,FDA,FDA-2007-D-0200,International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; Availibilty,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-02-16T04:59:59Z,2008-05-28T19:58:35Z,,0,0,090000648042abc7
FDA-2005-D-0013-0008,FDA,FDA-2005-D-0013,FDA,Notice,NAD-Notice of Availability of Data,2007-12-18T05:00:00Z,2007,12,2007-12-14T05:00:00Z,2008-12-16T04:59:59Z,2008-04-11T23:46:16Z,,0,0,090000648043e53f
FDA-2007-N-0319-0001,FDA,FDA-2007-N-0319,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Health and Diet Survey,Notice,30 Day Proposed Information Collection,2007-12-17T05:00:00Z,2007,12,2007-12-13T05:00:00Z,2008-01-15T04:59:59Z,2025-07-18T17:30:47Z,E7-24123,0,0,090000648042b7c7
FDA-2007-N-0441-0002,FDA,FDA-2007-N-0441,"Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions",Notice,General Notice,2007-12-12T05:00:00Z,2007,12,2007-12-12T05:00:00Z,2007-12-18T04:59:59Z,2025-08-19T20:24:09Z,07-6023,0,0,090000648042dda4
FDA-2007-N-0272-0002,FDA,FDA-2007-N-0272,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Presubmission Conferences, New Animal Drug Applications and Supporting Regulations and Guidance 152, and Form FDA 356V",Notice,30 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-01-11T04:59:59Z,2025-07-23T19:31:13Z,E7-23998,0,0,090000648042b3bd
FDA-2007-N-0220-0002,FDA,FDA-2007-N-0220,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Pharmacogenomic Data Submissions; Extension,Notice,30 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-01-11T04:59:59Z,2025-08-07T22:57:55Z,E7-23996,0,0,090000648042adfb
FDA-2007-N-0383-0003,FDA,FDA-2007-N-0383,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Radioactive Drug Research Committees,Notice,30 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-10T05:00:00Z,2008-01-11T04:59:59Z,2025-08-11T16:06:25Z,E7-23977,0,0,090000648042d750
FDA-2007-C-0044-0002,FDA,FDA-2007-C-0044,"DSM Nutritional Products, Inc.; Filing of Color Additive Petition",Notice,NFL-Notice of Filing,2007-12-11T05:00:00Z,2007,12,2007-12-03T05:00:00Z,,2026-01-08T20:19:27Z,,0,0,0900006480429647
FDA-2007-N-0080-0001,FDA,FDA-2007-N-0080,Establishment of Fiscal Year 2008 User Fee Rates for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products,Notice,General Notice,2007-12-11T05:00:00Z,2007,12,,,2025-08-19T00:31:05Z,E7-24000,0,0,09000064804298e2
FDA-2007-N-0266-0001,FDA,FDA-2007-N-0266,Agency Information Collection Activities; Proposed Collection; Comment Request; Reports of Corrections and Removals,Notice,N-Notice,2007-12-11T05:00:00Z,2007,12,2007-12-11T05:00:00Z,2008-02-12T04:59:59Z,2025-08-18T23:08:07Z,E7-23962,0,0,090000648042b37a
FDA-2000-P-0152-0010,FDA,FDA-2000-P-0152,FDA,Notice,NEC-Notice of Extension,2007-12-11T05:00:00Z,2007,12,2007-12-10T05:00:00Z,2008-02-12T04:59:59Z,2008-04-25T01:44:24Z,,0,0,09000064804d1371
FDA-2007-N-0087-0001,FDA,FDA-2007-N-0087,Agency Information Collection Activities; Proposed Collection; Comment Request; Mental Models Study of Communicating With Health Care Providers About the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women With Chronic Conditions,Notice,60 Day Proposed Information Collection,2007-12-11T05:00:00Z,2007,12,2007-12-10T05:00:00Z,2008-02-12T04:59:59Z,2025-09-24T22:10:20Z,E7-23976,0,0,0900006480429c98
FDA-2006-N-0239-0007,FDA,FDA-2006-N-0239,Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Final Rule,Notice,Notice of Final Rule,2007-12-06T05:00:00Z,2007,12,2007-12-05T05:00:00Z,,2015-12-15T17:50:54Z,,0,0,0900006480456f42
FDA-2007-F-0330-0001,FDA,FDA-2007-F-0330,"General Mills, Inc.; Filing of Food Additive Petition (FAP 7M4770)",Notice,NFL-Notice of Filing,2007-12-04T05:00:00Z,2007,12,2007-11-30T05:00:00Z,,2026-01-08T19:37:41Z,,0,0,090000648042b848
FDA-2007-N-0074-0001,FDA,FDA-2007-N-0074,Number not used,Notice,NFL-Notice of Filing,2007-12-04T05:00:00Z,2007,12,2007-12-03T05:00:00Z,,2008-04-04T00:35:37Z,,0,0,090000648042988b
FDA-1995-N-0061-0001,FDA,FDA-1995-N-0061,FDA,Notice,NWL-Notice of Withdrawl,2007-12-04T05:00:00Z,2007,12,2007-12-03T05:00:00Z,,2008-05-16T22:33:32Z,,0,0,090000648056c4d1
FDA-2007-N-0443-0003,FDA,FDA-2007-N-0443,FDA,Notice,NFL-Notice of Filing,2007-12-03T05:00:00Z,2007,12,2007-11-30T05:00:00Z,,2008-04-04T00:36:42Z,,0,0,090000648042ddc0
FDA-2007-N-0323-0002,FDA,FDA-2007-N-0323,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles,Notice,30 Day Proposed Information Collection,2007-12-03T05:00:00Z,2007,12,2007-12-03T05:00:00Z,2008-01-03T04:59:59Z,2025-07-29T23:35:15Z,E7-23351,0,0,090000648042b7f5
FDA-2007-N-0443-0002,FDA,FDA-2007-N-0443,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Color Additive Certification Requests and Recordkeeplng,Notice,30 Day Proposed Information Collection,2007-12-03T05:00:00Z,2007,12,2007-12-03T05:00:00Z,2008-01-03T04:59:59Z,2025-07-28T17:46:21Z,E7-23352,0,0,090000648042ddbe
FDA-2005-D-0445-0007,FDA,FDA-2005-D-0445,"Guidance for Industry and Food and Drug Administration Staff: Class II
Special Controls Guidance Document: Automated Blood Cell Separator
Device Operating by Centrifugal or Filtration Separation Principle;
Availability",Notice,Notice of Availability,2007-11-30T05:00:00Z,2007,11,2007-11-30T05:00:00Z,,2015-01-20T23:53:18Z,,0,0,09000064804505f1
FDA-1976-N-0026-0001,FDA,FDA-1976-N-0026,"Cold, Cough, Allergy, Bronchodilator and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amerndment of Final Monograph for OTC Antitussive Drug Products; Technical Amendment - Notice of Final Rule",Notice,NFR-Notice of Final Rule,2007-11-30T05:00:00Z,2007,11,,,2014-10-14T17:01:15Z,72,0,0,090000648051b4ed
FDA-2007-N-0198-0007,FDA,FDA-2007-N-0198,"Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Reopening of Comment Period - Notice of Extension",Notice,NEC-Notice of Extension,2007-11-30T05:00:00Z,2007,11,2007-11-30T05:00:00Z,2008-01-16T04:59:59Z,2009-03-31T19:50:39Z,,0,0,090000648042a9d6
FDA-2005-N-0286-0002,FDA,FDA-2005-N-0286,Medical Devices; Hematology and Pathology Devices; Reclassification of Automated Blood Cell Separator Device Operating by Centrifugal Separation Principle,Notice,Notice of Final Rule,2007-11-30T05:00:00Z,2007,11,2007-11-30T05:00:00Z,,2025-09-16T20:42:17Z,E7-23285,0,0,0900006480445883
FDA-2007-N-0450-0001,FDA,FDA-2007-N-0450,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution,Notice,30 Day Proposed Information Collection,2007-11-30T05:00:00Z,2007,11,2007-11-30T05:00:00Z,2008-01-01T04:59:59Z,2025-08-07T23:39:14Z,E7-23275,0,0,090000648042de6d
FDA-2006-F-0056-0004,FDA,FDA-2006-F-0056,Secondary Direct Food Additives Permitted in Food for Human Consumption,Notice,Notice of Final Rule,2007-11-29T05:00:00Z,2007,11,2007-11-29T05:00:00Z,2008-01-01T04:59:59Z,2026-01-07T18:53:53Z,E7-23182,0,0,090000648044416c
FDA-2006-F-0056-0003,FDA,FDA-2006-F-0056,Secondary Direct Food Additives Permitted in Food for Human Consumption,Notice,Notice of Final Rule,2007-11-29T05:00:00Z,2007,11,2007-11-29T05:00:00Z,2008-01-01T04:59:59Z,2026-01-07T18:50:12Z,E7-23182,0,0,090000648044416b
FDA-1978-N-0018-0612,FDA,FDA-1978-N-0018,"Sunscreen Drug Products for Over-The-Counter Human Use; Proposed
Amendment of Final Monograph; Extension of Comment Period",Notice,Notice of Extension,2007-11-28T05:00:00Z,2007,11,2007-11-28T05:00:00Z,2007-12-27T04:59:59Z,2019-08-01T16:04:23Z,07-5853,0,0,090000648055c00d
FDA-2007-N-0361-0001,FDA,FDA-2007-N-0361,FDA,Notice,"NRD-Notice of Requesting Data, Info, & Views",2007-11-28T05:00:00Z,2007,11,2007-11-27T05:00:00Z,2008-01-29T04:59:59Z,2008-04-04T00:36:26Z,,0,0,090000648042ba35
FDA-2006-P-0006-0004,FDA,FDA-2006-P-0006,"Determination That ELOXATIN (Oxaliplatin for Injection), 50 and 100
Milligrams Per Vial, Sterile Lyophilized Powder for Injection, Was Not
Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,N-Notice,2007-11-27T05:00:00Z,2007,11,2007-11-23T05:00:00Z,,2024-11-14T14:37:17Z,,0,0,0900006480441444
FDA-2006-P-0069-0004,FDA,FDA-2006-P-0069,Notice of Determination,Notice,N-Notice,2007-11-27T05:00:00Z,2007,11,2007-11-23T05:00:00Z,,2024-11-13T14:49:01Z,,0,0,0900006480444464
FDA-2005-P-0371-0002,FDA,FDA-2005-P-0371,FDA,Notice,NPR-Notice of Proposed Rule-Making,2007-11-27T05:00:00Z,2007,11,2007-11-26T05:00:00Z,2008-02-12T04:59:59Z,2008-04-12T00:10:08Z,,0,0,090000648044b3d9
FDA-2006-P-0085-0004,FDA,FDA-2006-P-0085,Notice of Determination,Notice,N-Notice,2007-11-27T05:00:00Z,2007,11,2007-11-23T05:00:00Z,,2024-11-04T19:38:04Z,,0,0,090000648044498c
FDA-2007-P-0247-0005,FDA,FDA-2007-P-0247,"Determination That ELOXATIN (Oxaliplatin for Injection), 50 and 100 Milligrams Per Vial, Sterile Lyophilized Powder for Injection, Was Not Withdrawn From Saie for Reasons of Safety or Effectiveness",Notice,N-Notice,2007-11-27T05:00:00Z,2007,11,2007-11-26T05:00:00Z,,2025-03-05T16:57:42Z,E7-22973,0,0,090000648042b113
FDA-2006-P-0201-0004,FDA,FDA-2006-P-0201,FDA Federal Register announcing the FDA Determination,Notice,N-Notice,2007-11-27T05:00:00Z,2007,11,2007-11-23T05:00:00Z,,2008-06-19T19:57:27Z,,0,0,0900006480450f51
FDA-2006-P-0224-0003,FDA,FDA-2006-P-0224,FDA,Notice,NPR-Notice of Proposed Rule-Making,2007-11-27T05:00:00Z,2007,11,2007-11-26T05:00:00Z,2008-02-12T04:59:59Z,2008-04-11T23:18:48Z,,0,0,0900006480456093
FDA-2007-N-0083-0017,FDA,FDA-2007-N-0083,Behind the Counter Availability of Certain Drugs; Public Meeting; Comment Period Clarification,Notice,NCR-Notice of Correction,2007-11-27T05:00:00Z,2007,11,2007-11-26T05:00:00Z,2007-12-18T04:59:59Z,2008-05-12T05:42:58Z,,0,0,0900006480429a98
FDA-2007-D-0132-0001,FDA,FDA-2007-D-0132,Draft Guidance for Industry on Smallpox (Variola) Infection: Developing Drugs for Treatment or Prevention,Notice,NAD-Notice of Availability of Data,2007-11-23T05:00:00Z,2007,11,2007-11-21T05:00:00Z,2008-01-23T04:59:59Z,2008-08-06T20:00:34Z,,0,0,090000648042a2b6
FDA-1999-D-0048-0006,FDA,FDA-1999-D-0048,International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Revised Guidance for Industry on Impurities in New Veterinary Medicinal Products (Revision); Availability,Notice,Notice of Data Availability,2007-11-23T05:00:00Z,2007,11,2007-11-21T05:00:00Z,2008-11-22T04:59:59Z,2025-06-10T19:14:10Z,E7-22901,0,0,09000064804a6009
FDA-2006-D-0299-0004,FDA,FDA-2006-D-0299,FDA,Notice,NAD-Notice of Availability of Data,2007-11-23T05:00:00Z,2007,11,2007-11-21T05:00:00Z,2008-11-22T04:59:59Z,2008-04-11T23:06:36Z,,0,0,0900006480458fb7
FDA-1999-D-0064-0005,FDA,FDA-1999-D-0064,International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Revised Guidance for Industry on Impurities in New Veterinary Drug Substances (Revision); Availability,Notice,Notice of Data Availability,2007-11-23T05:00:00Z,2007,11,2007-11-21T05:00:00Z,2008-11-22T04:59:59Z,2025-06-12T19:51:21Z,E7-22902,0,0,09000064804a67af
FDA-2004-D-0298-0003,FDA,FDA-2004-D-0298,FDA,Notice,NEC-Notice of Extension,2007-11-23T05:00:00Z,2007,11,2007-11-21T05:00:00Z,,2008-04-12T00:35:32Z,,0,0,0900006480472d20
FDA-2007-N-0154-0001,FDA,FDA-2007-N-0154,Agency Information Collection Activities; Proposed Collection; Comment Request; Recordkeeping and Records Access Requirements for Food Facilities,Notice,60 Day Proposed Information Collection,2007-11-20T05:00:00Z,2007,11,2007-11-19T05:00:00Z,2008-01-19T04:59:59Z,2025-08-15T21:26:09Z,E7-22480,0,0,090000648042a457
FDA-2006-F-0313-0001,FDA,FDA-2006-F-0313,"ARCH Chemicals, Inc.; Withdrawal of Food Additive Petition FAP 6B4764",Notice,Withdrawal,2007-11-20T05:00:00Z,2007,11,2007-11-19T05:00:00Z,,2025-12-17T19:50:52Z,E7-22536,0,0,090000648045c904
FDA-2007-N-0447-0003,FDA,FDA-2007-N-0447,FDA,Notice,N-Notice,2007-11-20T05:00:00Z,2007,11,2007-11-16T05:00:00Z,,2008-04-04T00:36:45Z,,0,0,090000648042de13
FDA-2007-N-0037-0002,FDA,FDA-2007-N-0037,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animal Drug User Fees and Fee Waivers and Reductions,Notice,30 Day Proposed Information Collection,2007-11-20T05:00:00Z,2007,11,2007-11-19T05:00:00Z,2007-12-20T04:59:59Z,2025-07-23T16:02:33Z,E7-22495,0,0,09000064804295db
FDA-2007-N-0217-0002,FDA,FDA-2007-N-0217,Agency Information Collection Activities: Submission for Office of Management and Budget Review; Comment Request; Medical Devices Third-Party Review Under the Food and Drug Administration Modernization Act,Notice,30 Day Proposed Information Collection,2007-11-20T05:00:00Z,2007,11,2007-11-19T05:00:00Z,2007-12-20T04:59:59Z,2025-07-23T18:31:50Z,E7-22586,0,0,090000648042add2
FDA-2007-N-0264-0002,FDA,FDA-2007-N-0264,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Registration of Cosmetic Product Establishments,Notice,30 Day Proposed Information Collection,2007-11-20T05:00:00Z,2007,11,2007-11-19T05:00:00Z,2007-12-20T04:59:59Z,2025-07-28T17:12:07Z,E7-22588,0,0,090000648042b346
FDA-2007-N-0085-0001,FDA,FDA-2007-N-0085,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds,Notice,30 Day Proposed Information Collection,2007-11-20T05:00:00Z,2007,11,,,2025-07-29T23:04:30Z,,0,0,0900006480429c7e
FDA-2007-N-0267-0001,FDA,FDA-2007-N-0267,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animal Drug User Fee Cover Sheet, FDA Form 3546",Notice,30 Day Proposed Information Collection,2007-11-20T05:00:00Z,2007,11,2007-11-20T05:00:00Z,2007-12-21T04:59:59Z,2025-07-23T16:52:02Z,E7-22649,0,0,090000648042b383
FDA-2007-N-0039-0001,FDA,FDA-2007-N-0039,Agency Emergency Processing Under Office of Management and Budget Review; Orphan Drug Products; Common European Medicines Evaluation Agency/Food and Drug Administration Application Form for Orphan Medicinal Product Designation,Notice,General Notice,2007-11-09T05:00:00Z,2007,11,2007-11-09T05:00:00Z,2007-11-20T04:59:59Z,2025-08-15T18:39:29Z,E7-21988,0,0,09000064804295f2
FDA-2007-M-0389-0001,FDA,FDA-2007-M-0389,"Medical Devices Regulated by the Center for Biologics Evaluation and Research; Availability of Summaries of Safety and Effectiveness Data for
Premarket Approval Applications",Notice,Notice of Data Availability,2007-11-09T05:00:00Z,2007,11,2007-11-09T05:00:00Z,,2026-01-13T02:23:08Z,E7-21986,0,0,090000648042d7c1
FDA-2007-N-0428-0001,FDA,FDA-2007-N-0428,Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Participation in the Medical Device Fellowship Program,Notice,60 Day Proposed Information Collection,2007-11-09T05:00:00Z,2007,11,2007-11-09T05:00:00Z,2008-01-09T04:59:59Z,2025-08-15T16:40:31Z,E7-21971,0,0,090000648042dc01
FDA-2007-D-0133-0001,FDA,FDA-2007-D-0133,See FDA-2007-D-0133-0003,Notice,,2007-11-09T00:00:00Z,2007,11,,,2008-05-28T00:54:44Z,,0,1,090000648042a2c0
FDA-2007-N-0314-0010,FDA,FDA-2007-N-0314,Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) - Notice of Public Meeting and Extension of Comment Period,Notice,NEC-Notice of Extension,2007-11-08T05:00:00Z,2007,11,2007-11-08T05:00:00Z,2007-12-20T04:59:59Z,2008-11-19T13:48:39Z,,0,0,090000648042b762
FDA-2007-N-0073-0001,FDA,FDA-2007-N-0073,Lederle Laboratories et al.; Withdrawal of Approval of 73 New Drug Applications and 62 Abbreviated New Drug Applications,Notice,Withdrawal,2007-11-08T05:00:00Z,2007,11,,,2025-09-16T21:26:14Z,E7-21886,0,0,0900006480429885
FDA-2007-N-0197-0001,FDA,FDA-2007-N-0197,Adolescent Over-the-Counter Drug Product Use; Public Workshop,Notice,Meeting,2007-11-05T04:00:00Z,2007,11,2007-11-05T05:00:00Z,2008-02-01T04:59:59Z,2025-09-16T18:54:47Z,E7-21713,0,0,090000648042a932
FDA-2002-D-0094-0003,FDA,FDA-2002-D-0094,"Draft Guidance for the Public, Food and Drug Administration Advisory Committee Members, and Food and Drug Administration Staff: Public Availability of Advisory Committee Members Financial Interest Information and Waivers; Availability",Notice,NAD-Notice of Availability of Data,2007-10-31T04:00:00Z,2007,10,2007-10-31T04:00:00Z,2008-01-01T04:59:59Z,2010-08-06T23:52:22Z,,0,0,090000648048e4a5
FDA-2007-D-0375-0001,FDA,FDA-2007-D-0375,FDA,Notice,NAD-Notice of Availability of Data,2007-10-30T04:00:00Z,2007,10,2007-10-29T04:00:00Z,2008-01-29T04:59:59Z,2008-07-21T19:57:16Z,,0,0,090000648042c89d
FDA-2007-F-0046-0002,FDA,FDA-2007-F-0046,Biomin GmbH; Filing of Food Additive Petition,Notice,Notice of Filing,2007-10-30T04:00:00Z,2007,10,2007-10-29T04:00:00Z,2008-01-01T04:59:59Z,2026-01-03T00:16:28Z,,0,0,090000648042965e
FDA-2005-D-0211-0050,FDA,FDA-2005-D-0211,FDA,Notice,NAD-Notice of Availability of Data,2007-10-29T04:00:00Z,2007,10,2007-10-26T04:00:00Z,,2008-04-11T23:46:52Z,,0,0,0900006480441500
FDA-2007-D-0069-0001,FDA,FDA-2007-D-0069,FDA,Notice,NAD-Notice of Availability of Data,2007-10-29T04:00:00Z,2007,10,2007-10-26T04:00:00Z,2008-01-29T04:59:59Z,2008-04-04T00:34:03Z,,0,0,0900006480429834
FDA-2007-D-0367-0001,FDA,FDA-2007-D-0367,Draft Guidance for Industry and Food and Drug Administration Staff; Impact Resistant Lenses: Questions and Answers; Availability,Notice,NAD-Notice of Availability of Data,2007-10-26T04:00:00Z,2007,10,2007-10-26T04:00:00Z,2008-01-25T04:59:59Z,2008-05-19T23:59:38Z,,0,0,090000648042bb4e
FDA-2003-N-0441-0002,FDA,FDA-2003-N-0441,Exocrine Pancreatic Insufficiency Drug Products; Extension to Obtain Marketing Approval,Notice,General Notice,2007-10-26T04:00:00Z,2007,10,2007-10-26T04:00:00Z,,2025-03-05T19:50:55Z,E7-21082,0,0,09000064804a245c
FDA-2007-D-0309-0001,FDA,FDA-2007-D-0309,Drug-Induced Liver Injury; Premarketing Clinical Evaluation; Draft Guidance,Notice,NAD-Notice of Availability of Data,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,2007-12-25T04:59:59Z,2008-08-27T17:27:07Z,72FR60681,0,0,090000648042b6c1
FDA-2006-N-0176-0003,FDA,FDA-2006-N-0176,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Continuous Marketing Applications: Pilot- Scientific Feedback and Interactions
During Development of Fast Track Products Under the Prescription Drug User Fee Act",Notice,Notice of Approval,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,,2025-06-20T17:24:04Z,E7-21056,0,0,0900006480450b60
FDA-2007-N-0446-0001,FDA,FDA-2007-N-0446,"User Fee Program for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products; Request for
Notification of Participation and Number of Advertisements for Review",Notice,General Notice,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,2007-11-27T04:59:59Z,2025-08-14T18:54:22Z,07-5282,0,0,090000648042de03
FDA-2007-D-0369-0002,FDA,FDA-2007-D-0369,Publication of Guidances for Industry Describing Product-Specific Bioequivalence Recommendations,Notice,NAD-Notice of Availability of Data,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,2007-12-25T04:59:59Z,2008-05-20T19:33:47Z,,0,0,090000648042bb9e
FDA-1999-N-0114-0007,FDA,FDA-1999-N-0114,"Notice of Approval re Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; CGMP for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV Infection (""Lookback"")",Notice,Notice of Approval,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,,2024-10-03T21:46:36Z,72FR48766,0,0,09000064804ae8e8
FDA-2007-D-0076-0001,FDA,FDA-2007-D-0076,FDA,Notice,NAD-Notice of Availability of Data,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,2008-01-24T04:59:59Z,2008-04-04T00:34:05Z,,0,0,090000648042989f
FDA-2006-N-0111-0004,FDA,FDA-2006-N-0111,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval;
Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs",Notice,Notice of Approval,2007-10-24T04:00:00Z,2007,10,2007-10-22T04:00:00Z,,2025-06-16T16:28:20Z,E7-20756,0,0,09000064804500c3
FDA-2007-D-0258-0001,FDA,FDA-2007-D-0258,FDA,Notice,NAD-Notice of Availability of Data,2007-10-24T04:00:00Z,2007,10,2007-10-18T04:00:00Z,,2008-04-04T00:34:20Z,,0,0,090000648042b1ca
FDA-2007-N-0363-0015,FDA,FDA-2007-N-0363,FDA,Notice,N-Notice,2007-10-24T04:00:00Z,2007,10,2007-10-19T04:00:00Z,2007-12-07T04:59:59Z,2008-04-04T00:36:28Z,,0,0,090000648042bacf
FDA-2007-P-0108-0004,FDA,FDA-2007-P-0108,Nonprescription Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2007-10-24T04:00:00Z,2007,10,2007-10-24T04:00:00Z,2007-12-31T04:59:59Z,2025-07-09T23:09:12Z,07-5249,0,0,0900006480429e46
FDA-2006-D-0168-0010,FDA,FDA-2006-D-0168,FDA,Notice,NAL-Notice of Approval,2007-10-19T04:00:00Z,2007,10,2007-10-19T04:00:00Z,,2008-04-11T23:03:24Z,,0,0,09000064804508f8
FDA-2007-D-0028-0001,FDA,FDA-2007-D-0028,FDA,Notice,NAD-Notice of Availability of Data,2007-10-19T04:00:00Z,2007,10,2007-10-19T04:00:00Z,,2008-04-04T00:34:00Z,,0,0,09000064804294a1
FDA-2007-N-0082-0002,FDA,FDA-2007-N-0082,Revision of the Requirements for Live Vaccine Processing,Notice,Notice of Final Rule,2007-10-19T04:00:00Z,2007,10,2007-10-17T04:00:00Z,2008-01-03T04:59:59Z,2025-07-29T17:31:25Z,E7-20610,0,0,0900006480429902
FDA-2000-N-0143-0002,FDA,FDA-2000-N-0143,"Applications for Food and Drug Administration Application Approval to Market a New Drug; Revision of
Postmarketing Reporting Requirements",Notice,Notice of Final Rule,2007-10-19T04:00:00Z,2007,10,2007-10-18T04:00:00Z,,2025-06-13T00:26:00Z,E7-20510,0,0,09000064804d0dec
FDA-2007-N-0362-0001,FDA,FDA-2007-N-0362,FDA,Notice,N-Notice,2007-10-19T04:00:00Z,2007,10,2007-10-19T04:00:00Z,,2008-04-04T00:36:26Z,,0,0,090000648042ba40
FDA-2007-N-0082-0001,FDA,FDA-2007-N-0082,Revision of the Requirements for Live Vaccine Processing; Companion to Direct Final Rule,Notice,NPR-Notice of Proposed Rule-Making,2007-10-19T04:00:00Z,2007,10,2007-10-18T04:00:00Z,2008-01-03T04:59:59Z,2025-07-30T09:00:20Z,E7-20609,0,0,09000064804298fe
FDA-2007-N-0216-0002,FDA,FDA-2007-N-0216,FDA,Notice,N-Notice,2007-10-19T04:00:00Z,2007,10,2007-10-19T04:00:00Z,2008-10-21T03:59:59Z,2008-04-04T00:36:03Z,,0,0,090000648042adc3
FDA-2000-D-0221-0007,FDA,FDA-2000-D-0221,FDA,Notice,NAL-Notice of Approval,2007-10-19T04:00:00Z,2007,10,2007-10-17T04:00:00Z,,2008-04-25T01:14:34Z,,0,0,09000064804d5177
FDA-2007-D-0420-0001,FDA,FDA-2007-D-0420,Draft Guidance for Industry on the Use of Mechanical Calibration of Dissolution Apparatus 1 and 2 Current Good Manufacturing Practice; Availability,Notice,NAD-Notice of Availability of Data,2007-10-19T04:00:00Z,2007,10,2007-10-19T04:00:00Z,2007-12-19T04:59:59Z,2008-04-19T00:59:52Z,,0,0,090000648042dab4
FDA-2007-N-0388-0004,FDA,FDA-2007-N-0388,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Toll-Free Number for Consumer
Reporting of Drug Product Side Effects: Comprehension",Notice,Notice of Approval,2007-10-17T04:00:00Z,2007,10,,,2025-07-01T23:39:15Z,E7-20075,0,0,090000648042d7b8
FDA-2001-D-0045-0002,FDA,FDA-2001-D-0045,FDA,Notice,N-Notice,2007-10-17T04:00:00Z,2007,10,2007-10-17T04:00:00Z,2007-12-18T04:59:59Z,2008-04-25T01:57:24Z,,0,0,09000064804b7519
FDA-2007-N-0040-0002,FDA,FDA-2007-N-0040,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Institutional Review Boards,Notice,30 Day Proposed Information Collection,2007-10-17T04:00:00Z,2007,10,2007-10-11T04:00:00Z,2007-11-14T04:59:59Z,2025-07-23T23:25:29Z,E7-20063,0,0,0900006480429604